Key Points
OVA-induced AAI is attenuated in Clec7a–/– mice.
Intestinal bacteria in Clec7a–/– mice can increase Treg cells in lungs.
Increased Treg cells in lungs are responsible for the suppression of AAI.
Abstract
Asthma is an allergic chronic respiratory disease that affects more than 300 million people around the world. Dysbiosis of intestinal commensal microbiota influences the development of asthma. Dectin-1 (gene symbol: Clec7a), a C-type lectin receptor, plays an important role in the intestinal immune homeostasis by controlling regulatory T (Treg) cell differentiation through regulation of intestinal microbiota. However, it is not clear whether intestinal immune conditions affect immune responses in other organs. In this study, we examined the effects of Dectin-1 deficiency on allergic airway inflammation (AAI). OVA-induced AAI was attenuated in Clec7a–/– mice. Treg cells were more abundant in colonic lamina propria, mesenteric lymph nodes, and bronchoalveolar lavage fluid of Clec7a–/– mice after AAI induction. Treatment with antibiotics, but not an antifungal agent, decreased the abundance of intestinal Treg cells and aggravated the symptoms of AAI in Clec7a–/– mice. Transplantation of gut microbiota from Clec7a–/– mice into antibiotic-treated hosts increased the abundance of intestinal Treg cells and ameliorated AAI. Overcolonization by Lactobacillus murinus, a Dectin-1 signaling-regulated commensal bacterium, also promoted expansion of Treg cells in the colon and suppressed lung inflammation. Depletion of Treg cells with anti-CD25 Ab eliminated the phenotypic differences between wild-type and Clec7a–/– mice in OVA-induced AAI. These observations suggest that inhibition of Dectin-1 signaling ameliorates AAI by increasing the abundance of Treg cells in lungs through modification of intestinal commensal bacteria, suggesting a role for commensal microbiota in regulating inflammation in organs other than the intestine.
Footnotes
↵1 Current address: Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
↵2 Current address: Department of Biological Repair, Field of Clinical Application Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
↵3 Current address: Department of Food, Agriculture and Environment, Miyagi University, Miyagi, Japan.
This work was supported by Japan Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid 20H04954 and 18H02671 (to Y.I.) and carried out in collaboration with Boehringer Ingelheim International.
The online version of this article contains supplemental material.
- Received November 30, 2020.
- Accepted February 16, 2021.
- Copyright © 2021 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.